Tottenham Acquisition I Ltd
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $40M
- Underwriters
- Focus
- Technology, Media, Telecommunications, TMT, Education, Healthcare, Consumer
- SEC Filings
- 1731176
- Public Embarc Page
- https://embarc.com/capital/spac/1731176/TOTA/tottenham-acquisition
- IPO Ticker
- TOTA
SPAC Leadership
Information on the SPAC leadership.
- Chairman, Chief Executive Officer and DirectorJason Ma
- Chief Financial Officer and DirectorFelix Wong
- DirectorSatoshi Tominaga
- DirectorAlbert Lyu
- DirectorEstela Kuo
Target Information
Information on the SPAC target for merger.
- Company
- Clene Nanomedicines
- Presentation
- Investor Presentation (SEC) on 2020-10-14
- Description
- Clene Nanomedicine is a clinical-stage biopharmaceutical company.